Are patients living far from hospital at higher risk of late adjuvant chemotherapy for colon cancer?
- PMID: 35293007
- DOI: 10.1111/bcp.15300
Are patients living far from hospital at higher risk of late adjuvant chemotherapy for colon cancer?
Abstract
Aims: Late adjuvant chemotherapy (aCT) administration after colectomy (>56 d) is known to be associated with impaired prognosis. We aim to identify risk factors associated with late aCT, especially the travel time between patients' home and hospital.
Methods: We performed a retrospective monocentre cohort study. Patients included had a colectomy for a stage III or high risk stage II colon cancer between 2009 and 2015 performed at a French university hospital. Risk factors for late aCT were identified using a fractional polynomial logistic regression.
Results: Ninety-four patients were included. The risk of late aCT was associated with travel time length, emergent colectomy, the need for scheduled care before aCT, and length of time between colectomy and postoperative multidisciplinary meeting advising aCT.
Conclusion: Our study suggests that, in patients with colon cancer, factors unrelated to disease severity and complexity could be associated with a higher risk of late aCT.
Keywords: adjuvant chemotherapy; colonic neoplasms; health services accessibility; time to treatment.
© 2022 British Pharmacological Society.
References
REFERENCES
-
- Sparling AS, Song E, Klepin HD, Foley KL. Is distance to chemotherapy an obstacle to adjuvant care among the N.C. Medicaid-enrolled colon cancer patients? J Gastrointest Oncologia. 2016;7(3):336-344. doi:10.21037/jgo.2016.02.01
-
- Haute Autorité de Santé. Guide ALD n° 30: Cancer colorectal. Accessed November 16, 2021. http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/ald_...
-
- Chau I, Norman AR, Cunningham D, et al. A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancer. Ann Oncol off J Eur Soc Med Oncol ESMO. 2005;16(4):549-557. doi:10.1093/annonc/mdi116
-
- Lima ISF, Yasui Y, Scarfe A, Winget M. Association between receipt and timing of adjuvant chemotherapy and survival for patients with stage III colon cancer in Alberta, Canada. Cancer. 2011;117(16):3833-3840. doi:10.1002/cncr.25954
-
- Hershman D, Hall MJ, Wang X, et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006;107(11):2581-2588. doi:10.1002/cncr.22316
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
